Indegene acquires Trilogy Writing & Consulting GmbH to enhance clinical and regulatory writing expertise
Acquiring Company
Indegene Limited
Acquired Company
Trilogy Writing & Consulting GmbH
Princeton
FrankfurtInformation TechnologyBiotechnologySoftwareHealth CareManagement ConsultingMedicalMedical DeviceDescription
Indegene, a digital-first, life sciences commercialization company, has announced the strategic acquisition of Trilogy Writing & Consulting GmbH, a global provider of specialty medical writing capabilities. This acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene’s depth of clinical and regulatory writing expertise for market authorization applications globally, aiming to benefit life sciences companies with higher productivity and lower cost.
Who to call at Indegene Limited, and when
When Indegene Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Indegene Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Indegene Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Indegene Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Indegene Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Trilogy Writing & Consulting GmbH?
Trilogy Writing & Consulting GmbH was acquired by Indegene Limited, based in Princeton. The deal was reported on March 27, 2024. Indegene Limited is a healthcare solutions provider that specializes in delivering integrated and innovative services to life sciences organizations. Indegene Limited is privately held and operates in Information Technology.
When did Indegene Limited acquire Trilogy Writing & Consulting GmbH?
Indegene Limited's acquisition of Trilogy Writing & Consulting GmbH was reported on March 27, 2024. Indegene, a digital-first, life sciences commercialization company, has announced the strategic acquisition of Trilogy Writing & Consulting GmbH, a global provider of specialty medical writing capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Trilogy Writing & Consulting GmbH do?
Trilogy Writing & Consulting is a medical writing consultancy with expertise in the development and delivery of clinical, regulatory, safety and medical content globally. It is privately held, operating in Medical, and is based in Frankfurt.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.